Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 31, 2018-02 ,pp. : 3328-3335

Bentham Science Publishers

Access to resources Recommend Favorite

Development of HuperTacrines as Non-Toxic, Cholinesterase Inhibitors for the Potential Treatment of Alzheimer’s Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 8, 2015-06 ,pp. : 648-658

Bentham Science Publishers

Access to resources Recommend Favorite

Simple Choline Esters as Potential Anti-Alzheimer Agents

By  

Current Pharmaceutical Design, Vol. 16, Iss. 6, 2010-02 ,pp. : 692-697

Bentham Science Publishers

Access to resources Recommend Favorite

Possibility of a New Anti-Alzheimer's Disease Pharmaceutical Composition Combining Memantine and Vitamin D

By Annweiler Cédric   Beauchet Olivier  

Drugs & Aging, Vol. 29, Iss. 2, 2012-02 ,pp. : 81-91

Adis International

Access to resources Recommend Favorite

Clinical Pharmacology of Novel Anti-Alzheimer Disease Modifying Medications

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 15, 2013-08 ,pp. : 1853-1863

Bentham Science Publishers

Access to resources Recommend Favorite